- Novavax, Inc. NVAX shares tumbled 82.9 percent to $1.43 after reporting disappointing results from two Phase 3 vaccine trials that had previously done well in the Phase 2 trial. According to the company, data from the Resolve Phase 3 trial for its vaccine for a potentially deadly respiratory virus didn't meet the efficacy objectives it had set.
- Real Goods Solar, Inc. RGSE declined 40.7 percent to $2.54. Real Goods Solar shares have dipped 84.26 percent over the past 52 weeks, while the S&P 500 index has gained 7.62 percent in the same period.
- Roka Bioscience Inc ROKA dipped 33.6 percent to $0.770. Roka Bioscience priced private placement of preferred stock and warrants.
- Concordia International Corp CXRX shares dropped 17.9 percent to $5.43. Concordia International issued comments on the UK's Health Service Medical Supplies (Costs) Bill and reaffirmed FY16 revenue guidance of $859 million to $888 million.
- Towerstream Corporation TWER shares fell 15.7 percent to $1.53. Towerstream priced its 2,962,963 shares offering at $1.35 per share.
- Histogenics Corp HSGX declined 11.6 percent to $2.96 as the company reported a $30.0 million private placement.
- Deutsche Bank AG (USA) DB shares dropped 9.3 percent to $13.40. The U.S. Department of Justice proposed the bank a $14 billion settlement related to probe of mortgage securities, the WSJ late last night reported. However, the bank said that it does not intend to settle near $14 billion.
- Netlist, Inc. NLST declined 8.8 percent to $1.25. Netlist priced an underwritten public offering of 8,000,000 shares at $1.25 per share.
- FelCor Lodging Trust Incorporated FCH shares dropped 7.7 percent to $6.04. JMP Securities downgraded FelCor Lodging Trust from Market Outperform to Market Perform.
- Oracle Corporation ORCL shares fell 4.2 percent to $39.16 as the company reported weaker-than-expected results for its first quarter and issued a downbeat profit forecast for the current quarter.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
